Sun, 29 Jan 2023

PHILADELPHIA, PA / ACCESSWIRE / November 25, 2022 / Kaskela Law LLC announces that it is investigating Xtant Medical Holdings Inc. ('Xtant') (NYSE:XTNT) on behalf of the Company's investors.

Since July 2021, shares of Xtant's common stock have declined in value from a trading price of $2.00 per share to a current trading price of less than $0.70 per share, a cumulative decline of over 65% in value.

The investigation seeks to determine whether Xtant and/or the company's representatives violated the securities laws by issuing false and/or misleading statements and/or failing to disclose material information to Xtant investors, thereby causing investor losses.

Xtant stockholders are encouraged to contact Kaskela Law LLC (Adrienne Bell, Esq.) at (484) 229 - 0750, or by email (abell@kaskelalaw.com) or online at https://kaskelalaw.com/cases/xtant-medical-holdings-inc/ , for additional information about this investigation and their legal rights and options.

Kaskela Law LLC exclusively represents investors in securities fraud, corporate governance, and merger & acquisition litigation. For additional information about Kaskela Law LLC please visit www.kaskelalaw.com. This notice may constitute attorney advertising in certain jurisdictions.

CONTACT:

KASKELA LAW LLC
D. Seamus Kaskela, Esq.
Adrienne Bell, Esq.
18 Campus Blvd., Suite 100
Newtown Square, PA 19073
(888) 715 - 1740
(484) 229 - 0750
www.kaskelalaw.com

SOURCE: Kaskela Law LLC



View source version on accesswire.com:
https://www.accesswire.com/728192/SHAREHOLDER-ALERT-Kaskela-Law-LLC-Announces-Investigation-of-Xtant-Medical-Holdings-Inc-XTNT-and-Encourages-Investors-with-Losses-to-Contact-the-Firm

More San Diego News

Access More

Sign up for San Diego News

a daily newsletter full of things to discuss over drinks.and the great thing is that it's on the house!